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editorial
Defining reference values 
for TSH: nearing perfection 
in a imperfect world
Definição de valores de referência para TSH: 
chegando à perfeição num mundo imperfeito
José Gilberto Henriques Vieira1
The use of diagnostic laboratory tests usually includes a comparison of the result obtained in a given patient to a reference range. The definition of this reference 
or “normal” range is a priori simple: one has to measure the analyte in a “normal” 
population using a reference method, and there you are! Unfortunately life is not that 
easy. Routine methods frequently provide results that are not exactly comparable to 
the reference methods and, worst of nightmares, we don’t really know what a “nor-
mal” population is.
Let’s take the example of TSH measurement. Thyroid Stimulating Hormone 
(TSH) is a complex glycoprotein that contains two different subunits (alpha and beta) 
that organize as a heterodimeric complex. Being a glycosylated protein, the amount 
of sugar can vary substantially with implications on the antibody recognition as well 
as on the biological action. As a consequence, several forms are found in circulation. 
The seminal work of Utiger (1) describing the first practical TSH radioimmunoassay, 
introduced the possibility of routine measurement of TSH and its use as a diagnostic 
tool for the diagnosis of thyroid diseases. Since that time (1965) measuring TSH has 
become an extremely useful tool in the study of thyroid diseases. The first radioimmu-
noassay methods for the measurement of TSH had limitations in sensitivity, and at that 
time TRH stimulation tests were used to define hyperthyroidism and borderline cases 
of hypothyroidism (2). With methodological evolution provided by the availability of 
monoclonal antibodies and the introduction of the non-competitive immunometric 
design, sensitivity no longer poses a problem (3). Automatic, extremely sensitive and 
reproducible methods are provided by all the major diagnostic companies, and are 
widely available for clinical use. Assay specificity and comparability is a pending issue, 
but efforts in standardization and harmonization of the most used assays are strongly 
being pursued (4).
Thyroid diseases are quite common and sometimes oligo or asymptomatic. As a 
consequence TSH measurement became one of the most requested laboratory tests. 
The fact that the TSH results do not follow a Gaussian distribution poses an extra 
challenge, mainly in the definition of the upper limit of the normal range. Additionally, 
TSH levels in the normal population present a higher inter than intra individual varia-
tion, in other words, one should interpret a given TSH value bearing in mind that each 
person has his own range of variation of thyroid hormone levels, a phenomenon very 
well described by the Danish group of Andersen and cols. (5). Genetic reasons may be 
behind this characteristic (6).
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In an effort to define a reliable normal range for 
TSH, the National Academy of Clinical Biochemistry 
(NACB, Washington, DC, USA) proposed very com-
plex selection criteria, including absence of family his-
tory, negativity for thyroid antibodies and no visible or 
palpable goiter (7). The inclusion of a normal ultraso-
nographic examination of the cervical region was later 
proposed by a German group and the result was that 
from a blood donor population (adult and otherwise 
healthy), only 52% were considered for the definition 
of normal range of TSH (8).
In this ABE&M issue, Rosario and cols. (9) publish 
a carefully designed paper defining the TSH normal 
values found in an adult Brazilian population. They 
used the same NACB criteria, without cervical ultraso-
nographic examination. From an initial population of 
1,611 volunteers, 40% were excluded for not fulfilling 
the inclusion criteria, and the TSH assay used in the 
study is one of the most employed in our country. In 
the final adult population studied (n = 960) the 2.5th 
and the 97.5th percentiles were 0.43 and 3.24 mUI/L, 
respectively. The stringency of the selection criteria can 
be evaluated by the observation that the minimum and 
maximum values were 0.35 and 4.8 mUI/L, respecti-
vely. These values are in concordance with most of the 
similar studies performed in different populations (8).
To have solid information about reference ranges 
is, by any perspective, extremely important. The availa-
bility of robust, sensitive and harmonized methods, as 
is the case nowadays for TSH, should prompt a more 
confident use of the assay results. However, one word 
of caution should be introduced with this new condi-
tion: to classify a patient as outside a normal range can 
have important implications. The diagnosis and treat-
ment of subclinical thyroid dysfunction, in special pa-
tients with slightly high TSH levels, is a still debatable 
issue (10). To have better laboratory methods, and to 
define strict normal ranges, amplifies our diagnostic ar-
mamentarium as well as our responsibility of properly 
using the information.
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